RIDGELAND and HATTIESBURG — Mississippi Technology Alliance (MTA) president and CEO Tony Jeff announced that Ablitech Inc., a biotechnology company based in Hattiesburg, has received a second round Research and Development investment from the Mississippi Seed Fund.
Ridgeland-based MTA invested $100,000 in Ablitech for further product and market development of Versadel, the company’s proprietary gene therapeutic delivery technology.
Ablitech received a first-round investment of $100,000 from the Seed Fund in Sept. 2009. The company achieved all goals and milestones in their first round of funding, which made them eligible for second round funding.
“MTA’s investment helps move our technology for delivering gene therapeutics from the laboratory to the marketplace,” said Ken Malone, co-founder and CEO of Ablitech.
The Mississippi Seed Fund was established by the Mississippi Legislature to provide start-up technology companies with access to pre-seed financing, early stage risk capital and product development capital to accelerate the development of high-performance, innovation-based business ventures in Mississippi. The fund is managed by the MTA.
Recipients must have a cash match from accredited investors to obtain funding.
BEFORE YOU GO…
… we’d like to ask for your support. More people are reading the Mississippi Business Journal than ever before, but advertising revenues for all conventional media are falling fast. Unlike many, we do not use a pay wall, because we want to continue providing Mississippi’s most comprehensive business news each and every day. But that takes time, money and hard work. We do it because it is important to us … and equally important to you, if you value the flow of trustworthy news and information which have always kept America strong and free for more than 200 years.
If those who read our content will help fund it, we can continue to bring you the very best in news and information. Please consider joining us as a valued member, or if you prefer, make a one-time contribution.Click for more info